H.R. 2629 - Antibiotic Development to Advance Patient Treatment Act
- Sponsor:
- John Shimkus
- Summary:
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the approval of certain antibacterial and antifungal drugs, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
Antibiotic Development to Advance Patient Treatment Act
H.R. 2629 — 114th Congress (2015–2016)
- Summary
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the approval of certain antibacterial and antifungal drugs, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the approval of certain antibacterial and antifungal drugs, and for other purposes.
- Other Titles
- Antibiotic Development to Advance Patient Treatment Act
- Antibiotic Development to Advance Patient Treatment Act
- Sponsor
- John Shimkus
- Co-Sponsors
- Subjects
- Health
- Administrative law and regulatory procedures
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Food and Drug Administration (FDA)
- Related Bills
- Major Actions
Introduced 6/03/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 6/03/2015 6/03/2015 Referred to the House Committee on Energy and Commerce. 6/03/2015 Introduced in House 6/05/2015 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
Contributions
- November - December 2014 For $107,164 Against $0
- January - February 2015 For $1,382,840 Against $0
- March - April 2015 For $2,991,125 Against $0
- May - June 2015 For $2,986,099 Against $0
- July - August 2015 For $1,672,553 Against $0
- September - October 2015 For $2,506,971 Against $0
- November - December 2015 For $2,096,775 Against $0
- January - February 2016 For $2,044,803 Against $0
- March - April 2016 For $3,211,026 Against $0
- May - June 2016 For $3,165,854 Against $0
- July - August 2016 For $1,930,252 Against $0
- September - October 2016 For $4,146,231 Against $0
- November - December 2016 For $404,499 Against $0
Votes
Contributions data source: OpenSecrets.org